| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |